Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome.
about
Primary and secondary transcriptional effects in the developing human Down syndrome brain and heartThe CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autismGenetic susceptibility and neurotransmitters in Tourette syndromeValidation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.Co-expression network analysis of Down's syndrome based on microarray data.Cell-type specific gene expression profiles of leukocytes in human peripheral blood.Identification of dysregulated genes in lymphocytes from children with Down syndrome.Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood.Expression of Reactive Oxygen Species-Related Transcripts in Egyptian Children With AutismHuman 45,X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of Turner syndrome.Ohnologs in the human genome are dosage balanced and frequently associated with disease.Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls.Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.Exon expression and alternatively spliced genes in Tourette Syndrome.Genomic expression patterns in menstrual-related migraine in adolescents.Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalanceClassification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypesTranscriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.mRNA blood expression patterns in new-onset idiopathic pediatric epilepsy.Genomics of brain and blood: progress and pitfalls.Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease.A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice.Genomic expression patterns in medication overuse headachesTrisomy 21 and Down syndrome: a short review.Genomic and Proteomic Biomarker Discovery in Neurological Disease.Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment.A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomasGene expression profiling for discovery of novel targets in human traumatic brain injury.Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans.The search for peripheral disease markers in psychiatry by genomic and proteomic approaches.RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke.Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.Prospective clinical trials to investigate clinical and molecular biomarkers.Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle.Genome-wide gene expression analysis in the placenta from fetus with trisomy 21.Aneuploidy: an important model system to understand salient aspects of functional genomics.Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects
P2860
Q21184170-F727D287-08D5-4C66-BEC1-1310667C9520Q24553624-45BBC843-5780-4E41-85C7-5FAA0825C126Q27008846-E8884516-F281-4799-99AA-B1208AA1292AQ30653697-51F84FC6-77CA-439E-A2B9-714978DCC7EDQ31126337-5C7872DC-A676-4D3B-AD8B-BC5DC4C70AE0Q33243638-E4E28418-1EE7-4BF5-8480-9D813CE7A526Q33324833-9CDB9EE8-7A20-4F35-A17E-CE3424A59D38Q33490843-AA82E281-FE62-4024-B69A-E71466E629F2Q33565752-C9175672-FBC5-4783-B0E7-8441E3225AE9Q33763587-21CF1340-3124-43AF-88B1-19BB26A77715Q33927314-58FC42CE-F5F2-4E77-A382-FC915DAA4978Q34427566-C4A97035-0768-4B33-9892-CD74536D6144Q34479257-37459FDD-07B2-4FAD-A323-F344258EBB15Q34758144-FBAE8018-5C75-405C-BB3E-BDAD5F3B3AECQ35693298-35958861-1359-4E7A-9C08-75486B52636AQ35946259-E7F193C2-8A85-4786-B134-13EEA0A5392BQ35946317-DB951E84-1949-4E5A-A72A-70CA134DBB7CQ36412663-C6EA4F79-E8C9-4475-9CC9-F51547462E46Q36592631-019C38DD-4B57-40B1-9408-F473B5C5ACD3Q36630115-C5F45071-09BA-42B3-B36E-BE3AC202CC47Q36883786-3003AC7B-3CF9-43E0-94D1-3BD2DCFB690EQ36948151-3AEB9FFE-A051-4CF7-9579-1AC29C1AA9CAQ36969032-451F05C7-F64F-4591-BBAE-065A4A96C08AQ37228422-B5AC9B19-4EB5-4EBD-976B-7DFA37EA0BC7Q37541706-3A855930-BF8C-4C44-B36F-233707E7C938Q37703975-92212BFC-8264-4301-9A9B-FA05642AD934Q37707565-BA7C2031-6289-4D22-870C-50783215D74CQ37812999-97DAAD8A-FECF-49AA-990B-17E1A0EA2ECFQ37866984-CF0F07EA-6A17-459F-90EE-5FCCD989D397Q38089247-A0E3EED7-231E-4103-AE17-9E639B854A99Q38103359-988BDDF3-753D-44F5-92AD-A7315BD5C909Q38296660-C016D8E3-7BCC-4EF5-BC0C-F6CC01203BE1Q38317059-F7A88164-59E0-45DF-9A0B-58A349FB3FECQ38450994-10ED19E1-AE47-4B5B-9AC5-EF563E292DFAQ38694561-DF4E67C2-FCEB-4DA7-913A-A22B13A42C76Q39489728-C2F190CD-782D-4C0E-93CA-3C657B8EBAA6Q41153664-65CED93F-C0D4-42CF-A640-3960851767E8Q47307659-122CA4AD-0346-41F6-B2E8-12EBB7FDB7C4Q57720147-655D85D9-935C-4A1A-8290-B595FB29C68B
P2860
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Blood expression profiles for ...... s type 1, and Down's syndrome.
@en
Blood expression profiles for ...... s type 1, and Down's syndrome.
@nl
type
label
Blood expression profiles for ...... s type 1, and Down's syndrome.
@en
Blood expression profiles for ...... s type 1, and Down's syndrome.
@nl
prefLabel
Blood expression profiles for ...... s type 1, and Down's syndrome.
@en
Blood expression profiles for ...... s type 1, and Down's syndrome.
@nl
P2093
P50
P356
P1433
P1476
Blood expression profiles for ...... s type 1, and Down's syndrome.
@en
P2093
Bonnie J Patterson
David N Franz
Elizabeth K Schorry
Francis J Hickey
Frank R Sharp
Mark B Schapiro
Matthew Wylie
Tina Narayan
Tracy A Glauser
P304
P356
10.1002/ANA.20291
P577
2004-12-01T00:00:00Z